You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LGH447

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML and High Risk MDS Trial in Worldwide (LGH447, LGH447 + midostaurin)

Completed
  • AML and High Risk MDS
  • LGH447
  • LGH447 + midostaurin
  • Ann Arbor, Michigan
  • +8 more
Dec 16, 2020

Multiple Myeloma Trial in Japan (LGH447)

Completed
  • Multiple Myeloma
  • LGH447
  • Nagoya-city, Aichi, Japan
  • +3 more
Dec 16, 2020

Multiple Myeloma Trial in Worldwide (LGH447, midazolam)

Completed
  • Multiple Myeloma
  • Chicago, Illinois
  • +7 more
Dec 16, 2020

Relapsed and Refractory Multiple Myeloma Trial in Worldwide (LGH447, BYL719)

Completed
  • Relapsed and Refractory Multiple Myeloma
  • Houston, Texas
  • +7 more
Dec 16, 2020

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022

Four Common Cancers Using the ctDNA Analysing Test

Recruiting
  • Cancer, Lung
  • +6 more
    • Hanoi, Vietnam
      Hanoi medical university
    Nov 23, 2022

    SARS-CoV Infection Trial in Lahore (convalescent plasma)

    Active, not recruiting
    • SARS-CoV Infection
    • convalescent plasma
    • Lahore, Punjab, Pakistan
      Muhammad Irfan Malik
    Dec 4, 2020